Vestmark Advisory Solutions, Inc. Biomarin Pharmaceutical Inc Transaction History

Vestmark Advisory Solutions, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 27, 2022	SELL	$74.28 - $92.69 $323,266 - $403,386	-4,352 Closed	0 $0
Q4 2021 Jan 31, 2022	BUY	$71.72 - $91.47 $11,833 - $15,092	165 Added 3.94%	4,352 $384,000
Q3 2021 Nov 15, 2021	BUY	$74.77 - $85.47 $13,383 - $15,299	179 Added 4.47%	4,187 $324,000
Q2 2021 Aug 09, 2021	BUY	$75.51 - $84.79 $3,775 - $4,239	50 Added 1.26%	4,008 $334,000
Q1 2021 May 10, 2021	SELL	$74.73 - $90.69 $106,564 - $129,323	-1,426 Reduced 26.49%	3,958 $299,000
Q4 2020 Feb 04, 2021	SELL	$72.61 - $90.2 $11,109 - $13,800	-153 Reduced 2.76%	5,384 $472,000
Q3 2020 Oct 19, 2020	BUY	$71.87 - $131.03 $61,808 - $112,685	860 Added 18.39%	5,537 $421,000
Q2 2020 Aug 13, 2020	BUY	$79.55 - $124.22 $18,216 - $28,446	229 Added 5.15%	4,677 $577,000
Q1 2020 May 06, 2020	BUY	$71.37 - $96.85 $317,453 - $430,788	4,448 New	4,448 $376,000
Q4 2019 Feb 14, 2020	SELL	$64.27 - $86.37 $285,680 - $383,914	-4,445 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$67.4 - $85.11 $71,444 - $90,216	1,060 Added 31.31%	4,445 $300,000
Q2 2019 Aug 20, 2019	BUY	$80.35 - $93.9 $271,984 - $317,851	3,385 New	3,385 $290,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Vestmark Advisory Solutions, Inc., based on Form 13F filings with the SEC.

Stay updated on Vestmark Advisory Solutions, Inc. with notifications on news.